Revenue
2018
2019
2020
2021
2022
2023
2024
2025
TherapeuticsMD, Inc. (TXMD)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2014
2015
2016
2017
2018
2019
2020
2021
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.0M | $1.8M | $1.3M | $70.0M | $2.6M | $64.9M | $49.6M | $16.1M | $16.8M | $19.4M | $20.1M | $15.0M | $8.8M | $3.8M | $2.1M | — |
| Gross profit | — | — | $1.3M | $68.6M | $1.2M | $48.9M | $43.3M | $13.4M | $14.1M | $15.2M | $15.6M | $11.4M | $6.8M | $2.5M | $1.1M | — |
| Research & development | — | — | — | — | $7.1M | $10.4M | $19.8M | $27.3M | $33.9M | $53.9M | $72.0M | $43.2M | $13.6M | $4.5M | $107,241 | — |
| Operating expenses | $7.4M | $7.9M | $9.8M | $67.4M | $80.7M | $204.4M | $194.5M | $143.6M | $91.8M | $105.4M | $100.8M | $65.4M | $32.6M | $18.6M | $6.6M | — |
| Operating income | −$4.4M | −$6.1M | −$8.5M | $1.2M | −$79.6M | −$155.5M | −$151.2M | −$130.2M | −$77.6M | −$90.3M | −$85.2M | −$54.0M | −$25.8M | −$16.1M | −$5.4M | — |
| EBITDAderived | −$4.0M | −$5.6M | −$7.6M | $2.4M | −$78.8M | −$151.5M | −$149.8M | −$129.9M | −$77.4M | −$90.1M | −$85.1M | −$54.0M | −$25.8M | −$16.1M | −$5.4M | — |
| Net income | −$569,000 | −$2.2M | −$10.3M | $112.0M | −$172.4M | −$183.5M | −$176.1M | −$132.6M | −$76.9M | −$89.9M | −$85.1M | −$54.2M | −$28.4M | −$35.1M | −$12.9M | −$2.9M |
| Basic EPSper diluted share | -$0.05 | -$0.19 | -$0.99 | $12.41 | -$21.66 | -$0.67 | -$0.72 | -$0.59 | -$0.37 | -$0.46 | -$0.49 | -$0.36 | -$0.22 | -$0.38 | -$0.21 | — |
| Diluted EPSper diluted share | -$0.05 | -$0.19 | -$0.99 | $11.96 | -$21.66 | -$0.67 | -$0.72 | -$0.59 | -$0.37 | -$0.46 | -$0.49 | -$0.36 | -$0.22 | -$0.38 | -$0.21 | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 23, 2025Form 4 | Thompson Tommy GDirector | BuyCommon Stock | 8.4K | $1.67 | $14.0K | 23.2K |
| Apr 14, 2025Form 4 | Thompson Tommy GDirector | BuyCommon Stock | 325 | $1.00 | $325.00 | 14.8K |
| Apr 14, 2025Form 4 | Walker Marlan DChief Executive Officer | BuyCommon Stock | 490 | $1.00 | $490.00 | 73.6K |
| Apr 10, 2025Form 4 | Walker Marlan DChief Executive Officer | BuyCommon Stock | 1.2K | $0.86 | $1.0K | 73.1K |
| Apr 9, 2025Form 4 | Walker Marlan DChief Executive Officer | BuyCommon Stock | 1.1K | $0.87 | $988.32 | 72.0K |